Gender-dependent effect of ACE I/D and AGT M235T polymorphisms on the progression of urinary albumin excretion in taiwanese with type 2 diabetes

American Journal of Nephrology

Volumn 29, Issue 4, 2009, Pages 299-308

  Tien, Kai Jen ^a,c   Hsiao, Jeng Yueh ^b   Hsu, Shih Chieh ^b   Liang, Hui Ting ^b   Lin, Shiu Ru ^d   Chen, Hung Chun ^b   Hsieh, Ming Chia ^b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d FOOYIN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Diabetes mellitus, type 2; Diabetic nephropathy; Gender variance; Gene polymorphism, ACE, AGT

Indexed keywords

ALBUMIN; ANGIOTENSINOGEN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ALLELE; ARTICLE; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RISK FACTOR; SEX DIFFERENCE; TAIWAN;

AGED; ALBUMINURIA; ANGIOTENSINOGEN; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; SEX CHARACTERISTICS; SEX DISTRIBUTION; TAIWAN;

EID: 53449093342     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000163592     Document Type: Article

References (40)

1. Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG: Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. dney Int 2006; 69: 2057-2063.
2. Parving HH, Tarnow L, Rossing P: Genetics of diabetic nephropathy. J Am Soc Nephrol 1996; 7: 2509-2517.
3. Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH: Progression of diabetic nephropathy. idney Int 2001; 59: 702-709. Jacobsen P, Tarnow L, Carstensen B, Hovind P, Poirier O, Parving HH: Genetic variation in the renin-angiotensin system and progression of diabetic nephropathy. J Am Soc Nephrol 2003; 14: 2843-2850.
4. Young RP, Chan JC, Critchley JA, Poon E, Nicholls G, Cockram CS: Angiotensinogen T235 and ACE insertion/deletion polymorphisms associated with albuminuria in Chinese type 2 diabetic patients. Diabetes Care 1998; 21: 431-437.
5. Tomino Y, Makita Y, Shike T, Gohda T, Haneda M, Kikkawa R, Watanabe T, Baba T, Yoshida H: Relationship between polymorphism in the angiotensinogen, angiotensinconverting enzyme or angiotensin II receptor and renal progression in Japanese NIDDM patients. Nephron 1999; 82: 139-144.
6. Wang J, Zhu X, Yang L, Liu Y, Zhou W, Li H: Relationship between angiotensinogen gene M235T variant with diabetic nephropathy in Chinese NIDDM. Chin Med J (Engl) 1999; 112: 797-800.
7. Remuzzi G, Perico N, Macia M, Ruggenenti P: The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Kidney Int Suppl 2005; 99:S57-S65.
8. van der Sman-de Beer F, Verhagen C, Rombach SM, Boorsma P, van Manen JG, Korevaar JC, van den Bogaard R, Boeschoten EW, Krediet RT, Navis GJ, Vandenbroucke JP, Dekker FW: ACE I/D polymorphism is associated with mortality in a cohort study of patients starting with dialysis. Kidney Int 2005; 68: 2237-2243.
9. Remuzzi A, Puntorieri S, Mazzoleni A, Remuzzi G: Sex related differences in glomerular ultrafiltration and proteinuria in Munich-Wistar rats. Kidney Int 1988; 34: 481-486.
10. Crook ED, Genous L, Oliver B: Angiotensinconverting enzyme genotype in blacks with diabetic nephropathy: effects on risk of diabetes and its complications. J Investig Med2003; 51: 360-365.
11. Lin CH, Yang WC, Tsai ST, Tung TH, Chou P: A community-based study of chronic kidney disease among type 2 diabetics in Kinmen, Taiwan. Diabetes Res Clin Pract 2007;75: 306-312.
12. Kuo HW, Tsai SS, Tiao MM, Yang CY: Epidemiological features of CKD in Taiwan. Am J Kidney Dis 2007; 49: 46-55.
13. Hall JE, Guyton AC, Jackson TE, Coleman TG, Lohmeier TE, Trippodo NC: Control of glomerular filtration rate by renin-angiotensin system. Am J Physiol 1977; 233:F366-F372.
14. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F: Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ace levels. Am J Hum Genet 1992; 51: 197-205.
15. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, opkins PN, Williams RR, Lalouel JM, et al: olecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71: 169-180.
16. Chang HR, Cheng CH, Shu KH, Chen CH, Lian JD, Wu MY: Study of the polymorphism of angiotensinogen, angiotensinconverting enzyme and angiotensin receptor in type II diabetes with end-stage renal disease in Taiwan. J Chin Med Assoc 2003; 66: 51-56.
17. Ha SK, Park HC, Park HS, Kang BS, Lee TH, Hwang HJ, Kim SJ, Kim DH, Kang SW, Choi , Lee HY, Han DS: ACE gene polymorphismand progression of diabetic nephropathy in Korean type 2 diabetic patients: effect of ACE gene DD on the progression of diabetic nephropathy. Am J Kidney Dis 2003; 41: 943-949.
18. Hsieh MC, Lin SR, Hsieh TJ, Hsu CH, Chen HC, Shin SJ, Tsai JH: Increased frequency of angiotensin-converting enzyme DD genotype in patients with type 2 diabetes in Taiwan. Nephrol Dial Transplant 2000; 15: 1008-1013.
19. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR: Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003; 63: 225-232.
20. Araki S, Koya D, Makiishi T, Sugimoto T, Isono M, Kikkawa R, Kashiwagi A, Haneda M: APOE polymorphism and the progression of diabetic nephropathy in Japanese subjects with type 2 diabetes: results of a prospective observational follow-up study. Diabetes Care 2003; 26: 2416-2420.
21. Wang Y, Ng MC, So WY, Tong PC, Ma RC, Chow CC, Cockram CS, Chan JC: Prognostic fect of insertion/deletion polymorphism of the ACE gene on renal and cardiovascular clinical outcomes in Chinese patients with type 2 diabetes. Diabetes Care 2005; 28: 348-354.
22. Park HC, Choi SR, Kim BS, Lee TH, Kang BS, Choi KH, Lee HY, Han DS, Ha SK: Polymorphism of the ACE gene in dialysis patients: overexpression of DD genotype in type 2 diabetic end-stage renal failure patients. Yonsei Med J 2005; 46: 779-787.
23. Ng DP, Tai BC, Koh D, Tan KW, Chia KS: Angiotensin-I converting enzyme insertion/ deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 nd comprising 14,727 subjects. Diabetologia 2005; 48: 1008-1016.
24. Neugarten J, Silbiger SR: Effects of sex hormones on mesangial cells. Am J Kidney Dis 1995; 26: 147-151.
25. Cherney DZ, Sochett EB, Miller JA: Gender differences in renal responses to hyperglycemia and angiotensin-converting enzyme inhibition in diabetes. Kidney Int 2005; 68: 1722-1728.
26. Gallagher PE, Li P, Lenhart JR, Chappell MC, Brosnihan KB: Estrogen regulation of angiotensin-converting enzyme mRNA. Hypertension 1999; 33: 323-328.
27. Ruggenenti P, Perna A, Zoccali C, Gherardi G, Benini R, Testa A, Remuzzi G: Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism. Gruppo Italiano di Studi Epidemologici in Nefrologia (Gisen). J Am Soc Nephrol 2000; 11: 88-96.
28. Gutierrez C, Vendrell J, Pastor R, Llor C, Aguilar C, Broch M, Richart C: Angiotensin I-converting enzyme and angiotensinogen ene polymorphisms in non-insulin-dependent diabetes mellitus. Lack of relationship with diabetic nephropathy and retinopathy in a Caucasian Mediterranean population. Metabolism 1997; 46: 976-980.
29. Hegele RA, Harris SB, Hanley AJ, Zinman B: Association between AGT T235 variant and microalbuminuria in Canadian Oji-Cree with type 2 diabetes mellitus. Clin Biochem 1999; 32: 201-205.
30. Wong TY, Chan JC, Poon E, Li PK: Lack of association of angiotensin-converting enzyme (DD/II) and angiotensinogen M235T gene polymorphism with renal function among Chinese patients with type II diabetes. Am J Kidney Dis 1999; 33: 1064-1070.
31. Lane PH, Steffes MW, Mauer SM: Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion. Diabetes 1992; 41: 581-586.
32. Tsalamandris C, Allen TJ, Gilbert RE, Sinha A, Panagiotopoulos S, Cooper ME, Jerums G: Progressive decline in renal function in diabetic patients with and without albuminuria. Diabetes 1994; 43: 649-655.
33. Kramer HJ, Nguyen QD, Curhan G, Hsu CY: Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 2003; 289: 3273-3277.
34. Schmidt S, Giessel R, Bergis KH, Strojek K, Grzeszczak W, Ganten D, Ritz E: Angiotensinogen gene m235T polymorphism is not associated with diabetic nephropathy. The Diabetic Nephropathy Study Group. Nephrol Dial Transplant 1996; 11: 1755-1761.
35. Freire MB, Ji L, Onuma T, Orban T, Warram JH, Krolewski AS: Gender-specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM. Hypertension 1998; 31: 896-899.
36. Rogus JJ, Moczulski D, Freire MB, Yang Y, Warram JH, Krolewski AS: Diabetic nephropathy is associated with AGT polymorphism 235: results of a family-based study. Hypertension 1998; 31: 627-631.
37. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin Iconverting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346.
38. Tsutaya S, Kitaya H, Saito Y, Nakata S, Takamatsu H, Yasujima M: Angiotensin converting enzyme gene polymorphism and its enzyme activity in serum in young Japanese females. Tohoku J Exp Med 1997; 182: 151-155.
39. Wu AY, Kong NC, de Leon FA, Pan CY, Tai TY, Yeung VT, Yoo SJ, Rouillon A, Weir MR: An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the microalbuminuria prevalence (MAP) study. Diabetologia 2005; 48: 17-26.
40. Chandie Shaw PK, Baboe F, van Es LA, van der Vijver JC, van de Ree MA, de Jonge N, Rabelink TJ: South-Asian type 2 diabetic patients have higher incidence and faster progression of renal disease compared with Dutch-European diabetic patients. Diabetes Care 2006; 29: 1383-1385.